Inhibition of inducible nitric oxide synthase in the human intestinal epithelial cell line, DLD-1, by the inducers of heme oxygenase 1, bismuth salts, heme, and nitric oxide donors
M. Cavicchi et al., Inhibition of inducible nitric oxide synthase in the human intestinal epithelial cell line, DLD-1, by the inducers of heme oxygenase 1, bismuth salts, heme, and nitric oxide donors, GUT, 47(6), 2000, pp. 771-778
Background-The inducible isoform of nitric oxide synthase (iNOS) may be inv
olved in the mucosal injury associated with inflammatory bowel disease (IBD
). In contrast with iNOS, the inducible heme oxygenase 1 (HO-1) is consider
ed to act as a protective antioxidant system.
Aims-To evaluate the effects of the known HO-1 inducers, cadmium and bismut
h salts, heme, and nitric oxide (NO) donors, on iNOS activity, and expressi
on in the human intestinal epithelial cell line DLD-1.
Methods-iNOS activity was assessed by the Griess reaction and the radiochem
ical L-arginine conversion assay. iNOS mRNA and iNOS protein expression wer
e determined by northern and western blotting, respectively.
Results-Cytokine exposure led to induction of iNOS activity, iNOS mRNA, and
iNOS protein expression. Preincubation of DLD-1 cells with heme (1-50 muM)
inhibited cytokine induced iNOS activity in a concentration dependent mann
er. This inhibitory effect was abolished by the HO-1 specific inhibitor tin
protoporphyrin. Preincubation with NO donors sodium nitroprusside (SNP 1-1
000 muM) or S-nitroso-acetyl-penicillamine (SNAP 1-1000 PM), or with the he
avy metals cadmium chloride (10-40 muM), bismuth citrate, or ranitidine bis
muth citrate (10-3000 muM) inhibited iNOS activity in a concentration depen
dent manner. Moreover, SNP and heme abolished cytokine induced iNOS protein
as well as iNOS mRNA expression, whereas cadmium chloride did not modify i
NOS protein expression.
Conclusions-Heme, the heavy cadmium and bismuth, as well as NO donors, are
potent inhibitors of cytokine induced iNOS activity. Heme and NO donors act
at the transcriptional level inhibiting iNOS mRNA expression. Such finding
s suggest the potential for interplay between the iNOS and HO-1 systems, wh
ich may modulate the progress of IBD.